Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Efficacy and Safety of Rapid-Acting Insulin Analogs in Special Populations with Type 1 Diabetes or Gestational Diabetes: Systematic Review and Meta-Analysis.

Nørgaard K, Sukumar N, Rafnsson SB, Saravanan P.

Diabetes Ther. 2018 Jun;9(3):891-917. doi: 10.1007/s13300-018-0411-7. Epub 2018 Apr 5. Review.

2.

A randomized controlled trial-based algorithm for insulin-pump therapy in hyperglycemic patients early after kidney transplantation.

Werzowa JM, Säemann MD, Mohl A, Bergmann M, Kaltenecker CC, Brozek W, Thomas A, Haidinger M, Antlanger M, Kovarik JJ, Kopecky C, Song PXK, Budde K, Pascual J, Hecking M.

PLoS One. 2018 Mar 8;13(3):e0193569. doi: 10.1371/journal.pone.0193569. eCollection 2018.

3.

Faster insulin action is associated with improved glycaemic outcomes during closed-loop insulin delivery and sensor-augmented pump therapy in adults with type 1 diabetes.

Ruan Y, Thabit H, Leelarathna L, Hartnell S, Wilinska ME, Tauschmann M, Dellweg S, Benesch C, Mader JK, Holzer M, Kojzar H, Evans ML, Pieber TR, Arnolds S, Hovorka R; AP@home consortium.

Diabetes Obes Metab. 2017 Oct;19(10):1485-1489. doi: 10.1111/dom.12956. Epub 2017 Jun 23.

4.

Using Insulin Infusion Sets in CSII for Longer Than the Recommended Usage Time Leads to a High Risk for Adverse Events: Results From a Prospective Randomized Crossover Study.

Pfützner A, Sachsenheimer D, Grenningloh M, Heschel M, Walther-Johannesen L, Gharabli R, Klonoff D.

J Diabetes Sci Technol. 2015 Sep 3;9(6):1292-8. doi: 10.1177/1932296815604438.

5.

Insulin analogs--is there a compelling case to use them? No!

Davidson MB.

Diabetes Care. 2014 Jun;37(6):1771-4. doi: 10.2337/dc13-2915.

6.

Stability and performance of rapid-acting insulin analogs used for continuous subcutaneous insulin infusion: a systematic review.

Kerr D, Wizemann E, Senstius J, Zacho M, Ampudia-Blasco FJ.

J Diabetes Sci Technol. 2013 Nov 1;7(6):1595-606. Review.

7.

Race, socioeconomic status, and treatment center are associated with insulin pump therapy in youth in the first year following diagnosis of type 1 diabetes.

Lin MH, Connor CG, Ruedy KJ, Beck RW, Kollman C, Buckingham B, Redondo MJ, Schatz D, Haro H, Lee JM, Tamborlane WV, Wood JR; Pediatric Diabetes Consortium.

Diabetes Technol Ther. 2013 Nov;15(11):929-34. doi: 10.1089/dia.2013.0132. Epub 2013 Jul 19.

8.

Conformational dynamics of insulin.

Hua QX, Jia W, Weiss MA.

Front Endocrinol (Lausanne). 2011 Oct 18;2:48. doi: 10.3389/fendo.2011.00048. eCollection 2011.

9.

Cumulative clinical experience with use of insulin lispro: critical appraisal, role in therapy, and patient considerations.

Uy J, Fogelfeld L, Guerra Y.

Diabetes Metab Syndr Obes. 2012;5:1-10. doi: 10.2147/DMSO.S15404. Epub 2012 Jan 10.

10.

Insulin glulisine in the management of diabetes.

Yamada S.

Diabetes Metab Syndr Obes. 2009 Jul 7;2:111-5.

11.

Pilot study for assessment of optimal frequency for changing catheters in insulin pump therapy-trouble starts on day 3.

Schmid V, Hohberg C, Borchert M, Forst T, Pfützner A.

J Diabetes Sci Technol. 2010 Jul 1;4(4):976-82.

12.

Patient treatment satisfaction after switching to NovoMix® 30 (BIAsp 30) in the IMPROVE™ study: an analysis of the influence of prior and current treatment factors.

Brod M, Valensi P, Shaban JA, Bushnell DM, Christensen TL.

Qual Life Res. 2010 Nov;19(9):1285-93. doi: 10.1007/s11136-010-9699-0. Epub 2010 Jul 4.

13.

An Achilles' heel in an amyloidogenic protein and its repair: insulin fibrillation and therapeutic design.

Yang Y, Petkova A, Huang K, Xu B, Hua QX, Ye IJ, Chu YC, Hu SQ, Phillips NB, Whittaker J, Ismail-Beigi F, Mackin RB, Katsoyannis PG, Tycko R, Weiss MA.

J Biol Chem. 2010 Apr 2;285(14):10806-21. doi: 10.1074/jbc.M109.067850. Epub 2010 Jan 27.

14.

An estimation of the long-term clinical and economic benefits of insulin lispro in Type 1 diabetes in the UK.

Pratoomsoot C, Smith HT, Kalsekar A, Boye KS, Arellano J, Valentine WJ.

Diabet Med. 2009 Aug;26(8):803-14. doi: 10.1111/j.1464-5491.2009.02775.x. Review.

15.

Improved glycemic control with intraperitoneal versus subcutaneous insulin in type 1 diabetes: a randomized controlled trial.

Logtenberg SJ, Kleefstra N, Houweling ST, Groenier KH, Gans RO, van Ballegooie E, Bilo HJ.

Diabetes Care. 2009 Aug;32(8):1372-7. doi: 10.2337/dc08-2340. Epub 2009 May 8.

16.

Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis.

Singh SR, Ahmad F, Lal A, Yu C, Bai Z, Bennett H.

CMAJ. 2009 Feb 17;180(4):385-97. doi: 10.1503/cmaj.081041.

17.

Past, present, and future of insulin pump therapy: better shot at diabetes control.

Sherr J, Tamborlane WV.

Mt Sinai J Med. 2008 Aug;75(4):352-61. doi: 10.1002/msj.20055. Review.

Supplemental Content

Support Center